Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19

03 Mar 20264 min read0 viewsJournal Feed

GIST

Annals of Internal Medicine, Volume 179, Issue 4 , Page 478-485, April 2026.

Clinical Editorial

Summary

Annals of Internal Medicine (ACP) published a clinical update in Research Highlights on 03 Mar 2026. The item focuses on Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Ann Intern MedRelated by Drugcovid-19metformin

Neither Metformin Nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae Of COVID-19

Research Highlights • 03 Mar 2026

JAMA IMRelated by Drugcovid-19metformin

Targeted Removal Of Soluble Fms-Like Tyrosine Kinase 1 In Very Preterm Preeclampsia

Research Highlights • 27 Apr 2026

BMJ OpenRelated by Drugmetformin

LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial

Research Highlights • 22 Apr 2026

Feed Metadata

Source

Annals of Internal Medicine (ACP)